FDA review of dupilumab for chronic spontaneous urticaria

Published Date: 13 Mar 2023

The FDA approval request for CSU is based on data from a pair of Phase 3 trials in two different populations.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pollution exposure may affect lung cancer in women who have never smoked

2.

younger kidney cancer survivors are more susceptible to heart problems.

3.

Q&A: Breast cancer facts that could save lives

4.

A prostate cancer risk prediction algorithm could help target men at highest risk

5.

New imaging guidelines for head and neck cancers, a step toward practice change


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot